Description
Farmatex (Myristalkonium Chloride) Vaginal Tablets 20 mg. №12 Tube
Composition
Active Ingredient: Myristalkonium chloride 20 mg per tablet.
Mechanism of Action
Farmatex vaginal tablets exert their therapeutic effects by disrupting the cell membranes of susceptible organisms, leading to their death. Myristalkonium chloride, the active ingredient, exhibits potent antimicrobial activity, targeting specific pathogens responsible for vaginal infections.
Pharmacological Properties
The pharmacological properties of Farmatex tablets are attributed to the antimicrobial action of myristalkonium chloride. This compound effectively inhibits the growth and proliferation of various microorganisms commonly implicated in vaginal infections, promoting the resolution of the condition.
Indications for Use
Indications: Farmatex vaginal tablets are indicated for the treatment of vaginal infections caused by susceptible organisms. These infections may include bacterial vaginosis, candidiasis, and other microbial imbalances in the vaginal flora.
Contraindications
Contraindications: Avoid using Farmatex tablets if you have a known allergy to myristalkonium chloride or any other components of the product. Consult with your healthcare provider for suitable alternative treatments in case of hypersensitivity reactions.
Side Effects
Common side effects associated with the use of Farmatex vaginal tablets may include mild vaginal irritation, itching, or discharge. In rare cases, individuals may experience allergic reactions characterized by swelling, redness, or difficulty breathing. Discontinue use and seek medical attention if severe side effects occur.
Usage Instructions
Dosage: Administer one tablet vaginally once daily, preferably before bedtime. Ensure proper hygiene by washing hands before and after insertion. Use the provided applicator to place the tablet deep into the vagina for optimal efficacy.
Benefits Compared to Analogues
Farmatex vaginal tablets offer a targeted approach to treating vaginal infections by delivering a precise dose of myristalkonium chloride directly to the affected area. This localized therapy minimizes systemic exposure and reduces the risk of developing antibiotic resistance, enhancing the overall effectiveness of the treatment.
Suitable Patient Groups
Farmatex tablets are suitable for use in adult women experiencing vaginal infections caused by susceptible pathogens. The product is not recommended for children or elderly individuals unless specifically prescribed by a healthcare provider based on individual clinical considerations.
Storage and Shelf Life
Store Farmatex vaginal tablets in a cool, dry place away from direct sunlight and moisture. Check the expiration date on the packaging and do not use the product if past the specified shelf life. Proper storage conditions help maintain the stability and integrity of the tablets for optimal therapeutic outcomes.
Packaging Description
Farmatex vaginal tablets are supplied in a convenient tube containing 12 tablets. The packaging is designed to ensure the protection and preservation of the product during storage and transportation. Each tablet is individually sealed to maintain its potency and sterility until use.
Clinical Evidence and Proven Effectiveness
Farmatex (Myristalkonium Chloride) Vaginal Tablets have undergone rigorous clinical evaluation to assess their efficacy in managing vaginal infections. Clinical studies have demonstrated that myristalkonium chloride exhibits robust antimicrobial properties, effectively combating a wide range of pathogens commonly associated with vaginal dysbiosis. The targeted delivery of this active ingredient via vaginal tablets enhances treatment outcomes and promotes microbial clearance, supporting the therapeutic benefits of Farmatex in clinical practice.
